Therapeutic alternatives in painful diabetic neuropathy: a meta-analysis of randomized controlled trials |
Vilar, Samuel
(Pain Clinic, University Hospital Virgen del Rocio)
Castillo, Jose Manuel (Department of Nursing, Physiotherapy and Podiatry, University of Seville) Martinez, Pedro V. Munuera (Department of Nursing, Physiotherapy and Podiatry, University of Seville) Reina, Maria (Department of Nursing, Physiotherapy and Podiatry, University of Seville) Pabon, Manuel (Department of Nursing, Physiotherapy and Podiatry, University Hospital Cruz Roja) |
1 | Richter RW, Portenoy R, Sharma U, Lamoreaux L, Bockbrader H, Knapp LE. Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebocontrolled trial. J Pain 2005; 6: 253-60. DOI |
2 | Campbell CM, Kipnes MS, Stouch BC, Brady KL, Kelly M, Schmidt WK, et al. Randomized control trial of topical clonidine for treatment of painful diabetic neuropathy. Pain 2012; 153: 1815-23. DOI |
3 | Rauck R, Makumi CW, Schwartz S, Graff O, Meno-Tetang G, Bell CF, et al. A randomized, controlled trial of gabapentin enacarbil in subjects with neuropathic pain associated with diabetic peripheral neuropathy. Pain Pract 2013; 13: 485-96. DOI |
4 | Weintraub MI, Herrmann DN, Smith AG, Backonja MM, Cole SP. Pulsed electromagnetic fields to reduce diabetic neuropathic pain and stimulate neuronal repair: a randomized controlled trial. Arch Phys Med Rehabil 2009; 90: 1102-9. DOI |
5 | Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128: 40-50. DOI |
6 | Asociacion Espanola de Enfermeria Vascular y Heridas (AEEVH). Guia de practica clinica: consenso sobre ulceras vasculares y pie diabetico. Segunda edicion. Seville, Asociacion Espanola de Enfermeria Vascular y Heridas. 2014. pp 1-90. |
7 | Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 2005; 28: 956-62. DOI |
8 | Kulkantrakorn K, Lorsuwansiri C, Meesawatsom P. 0.025% capsaicin gel for the treatment of painful diabetic neuropathy: a randomized, double-blind, crossover, placebo-controlled trial. Pain Pract 2013; 13: 497-503. DOI |
9 | National Institute for Health and Care Excellence (NICE). Neuropathic pain in adults: the pharmacological management of neuropathic pain in adults in non-specialist settings. NICE clinical guideline. London, National Institute for Health and Care Excellence. 2013. |
10 | Finnerup NB, Attal N, Haroutounian S, McNicol E, Baron R, Dworkin RH, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 2015; 14: 162-73. DOI |
11 | Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010; 17: 1113-23, e67-e88. DOI |
12 | Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12. DOI |
13 | Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: d5928. DOI |
14 | Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011] [Internet]. London, The Cochrane Collaboration. 2011 [cited 2018 March 3]. Available at http://handbook-5-1.cochrane.org/. |
15 | Stein C, Eibel B, Sbruzzi G, Lago PD, Plentz RD. Electrical stimulation and electromagnetic field use in patients with diabetic neuropathy: systematic review and meta-analysis. Braz J Phys Ther 2013; 17: 93-104. DOI |
16 | Schreiber AK, Nones CF, Reis RC, Chichorro JG, Cunha JM. Diabetic neuropathic pain: physiopathology and treatment. World J Diabetes 2015; 6: 432-44. DOI |
17 | Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, et al. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebocontrolled trial. Arch Phys Med Rehabil 2003; 84: 736-46. DOI |
18 | Bril V, England J, Franklin GM, Backonja M, Cohen J, Del Toro D, et al. Evidence-based guideline: treatment of painful diabetic neuropathy: report of the American academy of neurology, the American association of neuromuscular and electrodiagnostic medicine, and the American academy of physical medicine and rehabilitation. Neurology 2011; 76: 1758-65. DOI |
19 | Park HJ, Moon DE. Pharmacologic management of chronic pain. Korean J Pain 2010; 23: 99-108. DOI |
20 | Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Phys Ther 2009; 89: 873-80. |
21 | Donofrio PD, Raskin P, Rosenthal NR, Hewitt DJ, Jordan DM, Xiang J, et al. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study. Clin Ther 2005; 27: 1420-31. DOI |
22 | Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 2005; 116: 109-18. DOI |
23 | Niesters M, Proto PL, Aarts L, Sarton EY, Drewes AM, Dahan A. Tapentadol potentiates descending pain inhibition in chronic pain patients with diabetic polyneuropathy. Br J Anaesth 2014; 113: 148-56. DOI |